COSCIENS Biopharma Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United States, and internationally. The company is headquartered in Toronto, Canada. Show more

222 BAY STREET, TORONTO, ON, CANADA, M5K 1E7, Toronto, ON, M5K 1E7, USA

BIOTECHNOLOGY

HEALTHCARE

Market Cap

8.642M

52 Wk Range

$0.83 - $14.80

Previous Close

$2.72

Open

$2.72

Volume

N/A

Day Range

$2.72 - $2.72

Enterprise Value

1.312M

Cash

9.333M

Avg Qtr Burn

-4.447M

Insider Ownership

1.48%

Institutional Own.

8.93%

Qtr Updated

06/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Avenanthramides Tablets (Avs) Details Mild inflammation	Phase 2a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Macimorelin (Macrilen®; GHRYVELIN™) Details Pediatric growth hormone deficiency	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.